EUVIMEDEUVIMED entdecken
Crossref

STW5-II and STW5 modulate common pathways in functional dyspepsia, irritable bowel syndrome and gastroesophageal reflux disease

G S Ulrich-Merzenich, A Shcherbakova, S Rabini, O Kelber, R M Ammar, H Aziz-Kalbhenn

Planta Medica · 01.03.2026 · 92 (03) · 200-201

DOI: 10.1055/s-0045-1814865 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.03.2026. Verfasst von G S Ulrich-Merzenich und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main functional gastrointestinal disorders (FGIDs) include Functional Dyspepsia (FD) and Irritable Bowel Syndrome (IBS) which often show symptoms overlapping with gastroesophageal reflux disease (GERD) [ 1 ]. STW5-II, a standardized combination of six plants, is indicated in Germany for the treatment of FD and IBS. STW5, from which it was derived, is also used in FD, IBS and GERD [ 2 ]. We analyzed the signaling pathways that are modulated by STW5-II and STW5 and are related to pathomechanisms of all three disease entities to improve our understanding of the modes of action of STW5 / STW5-II as well as of potential joint pathomechanisms of the FGIDs. We analyzed data (Deep Sequencing, RT-PCR, Microarrays, Elisa, Proteomprofiling) obtained from our previous experiments [ 3 ] [ 4 ]. Colon cells had been treated with STW5-II and its single constituents (FD, IBS). HET1a cells and rat oesophageal tissue of Sprague Dawley rat had been treated with STW5 and its single constituents (GERD). The pathways modulated by STW5-II / STW5 in all three models related to immune responses, e.g. T-helper 1 type immune response, cytokine regulations (interferon, interleukin 1, interleukin 2, interleukin 6, interleukin 8, interleukin 10, interleukin 12) and mast cell activity, but also to functions related to muscle activity and transport (cell junction proteins, vasoconstrictions) as well as neural activities. Effects of the single extracts were not additive. Modulated pathways are related to functional activities that are relevant to treat FD, IBS and GERD. Further analyses are required to understand their interplay as prerequisite for personalized treatment approaches [ 5 ]. Publication History Article published online: 05 March 2026 © 2026. Thieme. All rights reserved. Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

Zitieren

APA

Ulrich-Merzenich, G. S., Shcherbakova, A., Rabini, S., Kelber, O., Ammar, R. M., & Aziz-Kalbhenn, H. (2026). STW5-II and STW5 modulate common pathways in functional dyspepsia, irritable bowel syndrome and gastroesophageal reflux disease. Planta Medica, 92(03), 200-201. https://doi.org/10.1055/s-0045-1814865

Vancouver

Ulrich-Merzenich GS, Shcherbakova A, Rabini S, Kelber O, Ammar RM, Aziz-Kalbhenn H. STW5-II and STW5 modulate common pathways in functional dyspepsia, irritable bowel syndrome and gastroesophageal reflux disease. Planta Medica. 2026;92(03):200-201. doi:10.1055/s-0045-1814865

BibTeX
@article{UlrichMerzenich2026,
  author = {Ulrich-Merzenich, G S and Shcherbakova, A and Rabini, S and Kelber, O and Ammar, R M and Aziz-Kalbhenn, H},
  title = {STW5-II and STW5 modulate common pathways in functional dyspepsia, irritable bowel syndrome and gastroesophageal reflux disease},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {03},
  pages = {200--201},
  doi = {10.1055/s-0045-1814865}
}
Kostenlos starten →